USPTO serial 79204234
EXIQON
Reviewed by CopyMark Law Group
Reg. 5547745Status 709
- Filing date
- Status date
- Registration date
- Aug 28, 2018
- Examiner
- MCCARTHY, BRIDGET ANN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EXIQON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biological products, namely, reagents and tissues and reagents for industrial and scientific purposes; diagnostic reagents, except for medical or veterinary use; biochemical reagents and products, comprising industrial chemicals, catalysts for chemical and biochemical processes and chemical assays for analysis of nucleic acid, nucleotide bases, oligo nucleotide bases, DNA and RNA, used for non-medical purposes; chemical reagents except for medical or veterinary purposes; biochemical kits comprising chemicals, catalysts for chemical and biochemical processes, chemical and biochemical assays, biochemical probes, biochemical reagents and enzymes, not for medical or veterinary purposes, for analysis of genes, nucleic acid, nucleotide bases, oligo nucleotide bases, DNA, RNA and microRNA and for detecting RNA and microRNA; biochemical probes and microarray probes for analysis of DNA, RNA, nucleotide bases, oligo nucleotide bases, nucleic acid and for detecting RNA and microRNA - not for medical and veterinary purposes | SECTION 71 - CANCELLED | — |
| 005 | Chemical, biochemical and biological preparations, products, namely, reagents and tissues, and reagents for pharmaceutical, medical and veterinary purposes, namely, clinical medical reagents, diagnostic reagents, and assays for medical use; chemical pharmaceutical preparations, namely, for use in the detection of cancer in humans and animals and for use in oncology and for use in the prevention, treatment and cure of cancer; chemical reagents for medical and veterinary purposes; chemical preparations for therapeutic purposes for the detection of cancer in humans and animals and for the treatment, prevention and cure of cancer and for use in oncology; diagnostic preparations for medical and veterinary purposes | SECTION 71 - CANCELLED | — |
| 009 | Apparatus for recording, transmission and reproduction of sound or images; prerecorded magnetic data carriers featuring information about biochemical research results and biochemical products and solutions for use in database management, prerecorded recording discs featuring information about biochemical research results and biochemical products and solutions for use in database management; compact discs, featuring data for use in connection with chemical and biochemical analyses of genes, DNA, RNA, nucleic acid, nucleotide bases, oligo nucleotide bases; DVDs, featuring data for use in connection with chemical and biochemical analyses of genes, DNA, RNA, nucleic acid, nucleotide bases, oligo nucleotide bases and other digital recording media, namely, prerecorded digital video discs and prerecorded digital versatile discs featuring information about biochemical research results and biochemical products and solutions; downloadable computer software for use in database management; downloadable cloud computing software for managing virtual machines on a cloud computing platform, and application software for computers for use in database management | SECTION 71 - CANCELLED | — |
| 042 | Research, development of chemical, biochemical and biological products, industrial analysis, validation experiments and non-business consultancy relating to chemical analyses of genes, nucleic acid, nucleotide bases, oligo nucleotide bases, DNA, RNA and microRNA; biotechnical consultancy relating to genes, nucleic acid, nucleotide bases, oligo nucleotide bases, DNA, RNA and microRNA, peptide syntheses and nucleotide syntheses; assay development, screening biomarker detection and development projects in the nature of biochemical and biological product development, sampling of biochemical and biological products, method development of analysis of genes, nucleic acid, nucleotide bases, oligo nucleotide bases, DNA, RNA and microRNA and validation projects in the nature of analysis of genes, nucleic acid, nucleotide bases, oligo nucleotide bases, DNA, RNA and microRNA, the aforesaid services for use in relation to biotechnological industry and biotechnological and biological research and development; biochemical and biological sequencing, the aforesaid services for use in relation to biotechnological industry and biotechnological and biological research and development; design and development of computer software, including cloud computing and application software for computers; scientific consultancy services relating to DNA peptide and nucleotide syntheses | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by QIAGEN GmbH
- Other trademarks owned by Exiqon A/S
- Other trademarks owned by Exiqon A/S
- Other trademarks owned by Exiqon A/S
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named EXIQON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 2, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 11, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 11, 2026 | INPC | INVALIDATION PROCESSED | — |
| Nov 14, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 14, 2025 | C71T | CANCELLED SECTION 71 | — |
| Apr 3, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 19, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 15, 2019 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jan 5, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 13, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 12, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 28, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 28, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 12, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 8, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 23, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 23, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 23, 2018 | NPUB | NOTICE OF PUBLICATION | — |
| May 8, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 3, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 2, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 2, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2017 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 15, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2017 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 27, 2017 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 25, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 25, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 23, 2017 | ALIE | ASSIGNED TO LIE | — |
| Oct 9, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 13, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 21, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 21, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 19, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 18, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 3, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 3, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 30, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |